Sponsored by Hudson Rock – Use Hudson Rock's free cybercrime intelligence tools to learn how Infostealer infections are impacting your business
Group: Worldleaks
Discovered by ransomware.live: 2025-07-21
Estimated attack date: 2025-05-26
Description:
[AI generated] InnoMedica is a Swiss-based biopharmaceutical firm focused on the development of tailored treatments for serious conditions such as cancer and neurological disorders. Its primary product, Talidox, is a nanomedical cancer drug that targets only tumor cells. InnoMedica's research is focused towards the technological advancements in medicine to provide more effective treatments.
DNS Records:
The following DNS records were found for the victim's domain.
Leak Screenshot:
Legal Disclaimer: Ransomware.live does not engage in the acquisition, exfiltration, downloading, possession, hosting, access, consultation, redistribution, or disclosure of unlawfully obtained data. This platform indexes only publicly visible information posted by ransomware operators and open web sources without accessing or obtaining the underlying stolen content. The service is provided to support public awareness, legitimate research, and cyber-resilience. No stolen personal or confidential data is collected or distributed via this site.